Table 3.

Effect of Cnnamon on Hemoglobin A1C (HbA1C) in Type 2 Diabetics

Baseline HbA1CFinal HbA1CDifferenceP*P
Treatment group (n = 55)8.47 ± 1.87.64 ± 1.7−0.83 (95% CI, 0.46–1.20)<.001
Control group (n = 54)8.28 ± 1.37.91 ± 1.5−0.37 (95% CI, 0.15–0.59).16
<.04
  • * Value between baseline and final HbA1C; unpaired 2-sample t test.

  • Value of mean difference between control and treatment; unpaired 2-sample t test.